PHIA.AS - Koninklijke Philips N.V.

Amsterdam - Amsterdam Delayed Price. Currency in EUR
42.51
-0.71 (-1.63%)
At close: 5:38PM CEST
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close43.22
Open42.74
Bid0.00 x 0
Ask0.00 x 0
Day's Range41.96 - 42.79
52 Week Range26.92 - 45.92
Volume2,613,210
Avg. Volume2,815,406
Market Cap38.658B
Beta (5Y Monthly)0.93
PE Ratio (TTM)37.72
EPS (TTM)1.13
Earnings DateJul 20, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 30, 2020
1y Target Est38.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Barrons.com

      How Chip-Equipment Maker ASML Is Powering Past the Pandemic

      The maker of pricey lithography systems for major chip makers ran into demand problems early in the outbreak. But now it’s looking to a post-Covid world of cloud computing, videogaming, and driverless cars.

    • Philips (PHG) Upgraded to Strong Buy: Here's What You Should Know
      Zacks

      Philips (PHG) Upgraded to Strong Buy: Here's What You Should Know

      Philips (PHG) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    • GlobeNewswire

      Philips data-driven Mask Selector delivers unique patient and business benefits

      July 9, 2020  First and only clinically-validated mask selection, sizing and fitting solution that helps providers fit patients with the right mask from the.

    • GlobeNewswire

      Philips and BioIntelliSense form strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home

      July 9, 2020  Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the.

    • Hedge Funds Are Warming Up To Koninklijke Philips NV (PHG)
      Insider Monkey

      Hedge Funds Are Warming Up To Koninklijke Philips NV (PHG)

      The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

    • Philips Ranked as World’s Most Innovative Medtech Company in Boston Consulting Group’s Annual Report
      Business Wire

      Philips Ranked as World’s Most Innovative Medtech Company in Boston Consulting Group’s Annual Report

      Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has earned a place on Boston Consulting Group’s (BCG) "The Most Innovative Companies 2020" ranking of the top 50 most innovative companies worldwide, moving up 6 spots from 2019. In its new 2020 position at number 23, Philips also ranks as the most innovative medtech company and is one of only 162 companies to have ever appeared on the list in its 14 years of publication.

    • Coronavirus Ups Demand for Air Purifiers: 4 Stocks to Watch
      Zacks

      Coronavirus Ups Demand for Air Purifiers: 4 Stocks to Watch

      More consumers are demanding HEPA filters amid the COVID-19 outbreak, thus leading to a significant rise in demand for air purifiers.

    • A Trio of Stocks Growing Earnings Fast
      GuruFocus.com

      A Trio of Stocks Growing Earnings Fast

      Their 5-year EPS growth rates beat the S&P; 500 Continue reading...

    • Ventilator Industry Pumps Up Amid Coronavirus: 3 Stocks in Focus
      Zacks

      Ventilator Industry Pumps Up Amid Coronavirus: 3 Stocks in Focus

      Amid the pandemic crisis, the ventilator industry gains on contributions from companies across various sectors.

    • Thomson Reuters StreetEvents

      Edited Transcript of PHIA.AS earnings conference call or presentation 20-Apr-20 8:00am GMT

      Q1 2020 Koninklijke Philips NV Earnings Call

    • Royal Philips (PHG) Gains But Lags Market: What You Should Know
      Zacks

      Royal Philips (PHG) Gains But Lags Market: What You Should Know

      In the latest trading session, Royal Philips (PHG) closed at $47.33, marking a +0.34% move from the previous day.

    • Thomson Reuters StreetEvents

      Edited Transcript of PHIA.AS earnings conference call or presentation 28-Jan-20 9:00am GMT

      Q4 2019 Koninklijke Philips NV Earnings Call

    • Philips Gets FDA Emergency Use Nod For Monitors, Displays During Covid-19 Pandemic
      SmarterAnalyst

      Philips Gets FDA Emergency Use Nod For Monitors, Displays During Covid-19 Pandemic

      Koninklijke Philips (PHG) said it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its monitors and displays to be used for Covid-19 patients in U.S. hospitals.The technology company said the emergency use authorization is for its IntelliVue Patient Monitors MX750 and MX850 as well as its IntelliVue Active Displays AD75 and AD85. The patient monitoring products help to collate infection-control protocols and remotely provide patient information for caregivers, which are much needed when caring for hospitalized COVID-19 patients, the company said.The FDA authorization enables the company to start delivering the new remote patient monitoring products to U.S. hospitals. Patient monitors, which enable clinicians to remotely monitor a patient’s condition can help hospitals minimize staff exposure to the virus that causes COVID-19.“As the world continues to battle against COVID-19, we’re committed to ramping up production of all critical solutions that can help in this time of crisis,” said Peter Ziese, General Manager, Monitoring and Analytics at Philips. “This FDA EUA for our MX750 and MX850 monitors and IntelliVue AD75 and AD85 Active Displays allows us to do that for these remote patient monitoring solutions, which are of vital need in the intensive care unit.”Furthermore, Philips said it is significantly increasing its patient monitor production to address the demand for more intensive care unit (ICU) capacity.Shares in Philips, which slumped to a multi-year low in March have since been on a steady gaining streak, advancing some 44%. The stock was little changed at $45.72 in midday U.S. trading.Last month, Kepler Capital analyst David Cerdan maintained a Hold rating on the stock with a $37.85 price target. Meanwhile, DZ Bank analyst Elmar Kraus upgraded Philips to Buy from Hold with a $41.19 price target.Following the stock’s recent rally, the $39.52 average price target implies 14% downside potential in the shares in the coming 12 months. (See Philips stock analysis on TipRanks).Related News: Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses Eli Lilly Starts Dosing Patients In World’s First Covid-19 Antibody Trial More recent articles from Smarter Analyst: * Sanofi Seeks Growth Strategy For Dupixent Drug To Meet €10B Peak Sales Target * Beyond Meat Boosts Europe Presence As Global Expansion Continues * Tesla Said To Have Won Chinese Nod To Build Model 3 Cars With LFP Batteries * Sorrento Soars 17% In Pre-Market On Covid-19 Test Application

    • Royal Philips Ranked Among Top 10 Largest Public Healthcare Companies in Forbes Annual Global 2000 Listing
      Business Wire

      Royal Philips Ranked Among Top 10 Largest Public Healthcare Companies in Forbes Annual Global 2000 Listing

      Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company once again has earned a place on the Forbes "Global 2000: The World’s Largest Public Companies" list, moving up 46 spots from 2019. In its new 2020 position, the company now also ranks as one of the top ten global public healthcare companies. The annual list, which has been released for the past 18 years, features a ranking of the biggest, most powerful and most valuable companies in the world. Philips ranked 385 out of the 2,000 publicly traded companies on the full list.

    • Masimo and Philips Licensing Agreement Brings Masimo NomoLine® Capnography and O3® Regional Oximetry to Select Philips Patient Monitors
      Business Wire

      Masimo and Philips Licensing Agreement Brings Masimo NomoLine® Capnography and O3® Regional Oximetry to Select Philips Patient Monitors

      Philips is integrating additional Masimo monitoring technologies into select Philips multi-parameter patient monitors.

    • EU signs contract with Philips on ventilators
      Reuters

      EU signs contract with Philips on ventilators

      Dutch electronics giant Philips signed a contract with the European Commission to supply medical ventilators to EU hospitals, the company and EU officials said, in a deal that comes as most EU countries reached the peak of the COVID-19 outbreak. Other companies have signed similar contracts with the European Union as part of a joint procurement scheme the Commission launched in March on behalf of 25 EU states.

    • Reuters

      U.S. arms makers and medical device firms team up to make ventilators

      U.S. weapons makers have teamed up with medical device companies to increase the supply of ventilators that can be used to combat the coronavirus pandemic, people working on the project said. The two groups do not regularly partner on projects, but when a defense industry consultant with an engineering background realized weapons makers could help solve supply-chain problems within the U.S. ventilator industry, the creation of Vent Connect was set in motion and is set to be announced on Monday, the people said. The idea gathered momentum when industry associations like the Aerospace Industries Association, which represents plane makers and defense contractors including Lockheed Martin Corp and General Dynamics Corp, teamed up with AdvaMed, the Advanced Medical Technology Association, whose members include vent manufacturers.

    • Moody's

      Signify N.V. -- Moody's assigns Baa3 rating to Signify's proposed senior unsecured notes

      Moody's Investors Service, ("Moody's") has today assigned a Baa3 rating to Signify N.V. (Signify) proposed issue of Euro-denominated floating and fixed rate senior unsecured notes. Moody's assesses Signify's liquidity profile as good.

    • U.S. revs up ventilator production for coronavirus patients as need wanes
      Reuters

      U.S. revs up ventilator production for coronavirus patients as need wanes

      The Trump administration, under pressure to do more to ramp up coronavirus testing in order to safely reopen the battered U.S. economy, is highlighting this week a $2.9 billion program to build 187,000 ventilators this year. The administration's ventilator surge is accelerating as medical experts are forecasting the need for the devices - used to help severely ill COVID-19 patients breathe - will fall. Many of the ventilators will now be sent to other countries in need, the administration says.

    • European stocks extend rally as recovery hopes continue
      MarketWatch

      European stocks extend rally as recovery hopes continue

      European stocks started higher on Monday, continuing the rally from coronavirus lows, on data showing the disease’s spread is slowing.

    • MarketWatch

      European stocks kick off week with early rise

      European stocks opened higher on Monday, gaining about 0.4% in early action. The Stoxx Europe 600 has climbed 7.9% over the last two weeks on optimism over the slowing spread of the coronavirus and the gradual reopening of economies. Vivendi and Philips each rose after reporting first-quarter results. U.S. stock futures slipped after the powerful Wall Street rally on Friday.

    • Reuters

      European shares rise as coronavirus death toll slows

      European shares edged higher on Monday as coronavirus deaths slowed in hotspots Italy and Spain, but the mood remained cautious with companies preparing to report their worst quarterly earnings since the 2008 financial crisis. The pan-European STOXX 600 index was up 0.4% at 0701 GMT, after ending Friday with its biggest two-week percentage gain since 2015.

    • Philips says modest growth possible, despite virus disruption
      Reuters

      Philips says modest growth possible, despite virus disruption

      Sales and profit margins at Dutch health technology company Philips <PHG.AS> could still rise this year, provided the coronavirus pandemic eases in the coming months and hospitals are able to restart elective operations, it said on Monday. The optimism contrasts with the gloom engulfing much of the corporate world as lockdowns to contain the pandemic hammer business, and partly reflects strong orders for Philips' medical ventilators used for treating the sickest coronavirus patients. The electric toothbrush to hospital scanners maker scrapped its previous 2020 forecasts for 4-6% comparable sales growth and a 100 basis point improvement in operating profit margin, as the disruption from the health crisis hit first-quarter results and it warned the second quarter could be even worse.

    • Moody's

      Bright Bidco B.V. -- Moody's downgrades Bright Bidco B.V. to Caa3; outlook negative

      Moody's Investors Service, ("Moody's") today downgraded the corporate family rating of Bright Bidco B.V. (BBBV, Lumileds) to Caa3 from Caa1 and the probability of default rating to Caa3-PD from Caa1-PD. Moody's also downgraded to Caa3 from Caa1 the senior secured term loan B (TLB) and the $200 million senior secured revolving credit facility, both with BBBV as the borrower. Moody's downgraded the ratings to Caa3 following extremely challenging conditions in BBBV's core end-markets automotive and consumer LED, which are additionally burdened by the impact from the covid 19 outbreak.